2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles-O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase) (vol 18, pg 6171, 2008)

被引:0
作者
Warmus, Joseph S. [1 ]
Flamme, Cathlin [1 ]
Zhang, Lu Yan [1 ]
Barrett, Stephen [1 ]
Bridges, Alexander [1 ]
Chen, Huifen [3 ]
Gowan, Richard [2 ]
Kaufman, Michael [1 ]
Sebolt-Leopold, Judy [2 ]
Leopold, Wilbur [2 ]
Merriman, Ronald [2 ]
Ohren, Jeffrey [3 ]
Pavlovsky, Alexander [3 ]
Przybranowski, Sally [2 ]
Tecle, Haile [1 ]
Valik, Heather [2 ]
Whitehead, Christopher [3 ]
Zhang, Erli [3 ]
机构
[1] Pfizer Global Res & Dev, Dept Chem, Ann Arbor, MI 48105 USA
[2] Pfizer Global Res & Dev, Dept Oncol Pharmacol, Ann Arbor, MI 48105 USA
[3] Pfizer Global Res & Dev, Discovery Technol Struct & Analyt Sci, Ann Arbor, MI 48105 USA
关键词
D O I
10.1016/j.bmcl.2008.10.135
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:3695 / 3695
页数:1
相关论文
共 1 条
[1]   2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles-O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase) [J].
Warmus, Joseph S. ;
Flamme, Cathlin ;
Zhang, Lu Yan ;
Barrett, Stephen ;
Bridges, Alexander ;
Chen, Huifen ;
Gowan, Richard ;
Kaufman, Michael ;
Sebolt-Leopold, Judy ;
Leopold, Wilbur ;
Merriman, Ronald ;
Ohren, Jeffrey ;
Pavlovsky, Alexander ;
Przybranowski, Sally ;
Tecle, Haile ;
Valik, Heather ;
Whitehead, Christopher ;
Zhang, Erli .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (23) :6171-6174